The GLP-1 drugs should have a big impact for type II diabetes. Interestingly Fresenius, a massive dialysis provider, has taken a beating in terms of stock pric

The GLP-1 drugs should have a big impact for type II diabetes. Interestingly Fresenius, a massive dialysis provider, has taken a beating in terms of stock price with the GLP-1 data. That said, diabetes is a long-term disease and it's going to take a decade or two to see a measurable difference.